All lobbying filings
FORBES-TATE
FORBES-TATE filed a Q1 report for INVIVYD on April 20, 2026, reporting $60,000 in lobbying income.
Lobbying for INVIVYD · Biopharmaceutical company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Connecticut
Government bodies contacted
2
Lobbying activity
1
Issues related to infectious diseases.